BioCentury
ARTICLE | Clinical News

AU-011: Ph Ib started

April 26, 2017 6:57 PM UTC

Aura began an open-label, U.S. Phase Ib trial to evaluate single injections of 2 dose levels of intravitreal AU-011 in up to 12 patients....

BCIQ Company Profiles

Aura Biosciences Inc.